Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2143046 | 0.86 | ALDH1A1 (0.52) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL25917458 | 0.86 | DNM1 (0.41) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL8377133 | 0.85 | NAAA (0.61) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL8374691 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL1671755 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL31136183 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL2854828 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL6667798 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL465967 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 | |
| SCHEMBL1672723 | 0.83 | NAAA (0.64) | DNM1NAAADGKAALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235559-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | Incisive Genetics Inc. (CA) | 2025-07-24 | — | — | US | claimed |
| EP-4577658-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, AMELIORATING, OR TREATING SICKLE CELL DISEASE AND COMPOSITIONS AND METHODS FOR DISRUPTING GENES AND GENE SEGMENTS | INCISIVE GENETICS, INC. (CA) | 2025-07-02 | — | — | EP | claimed |
| EP-4463555-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | INCISIVE GENETICS, INC. (CA) | 2024-11-20 | — | — | EP | claimed |
| US-20240358652-A1 | LIPID NANOPARTICLE FORMULATIONS | MONASH UNIVERSITY (AU) | 2024-10-31 | — | — | US | claimed |
| US-20240293300-A1 | SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD | SHISEIDO COMPANY, LTD. (JP) | 2024-09-05 | — | — | US | claimed |
| EP-4409004-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, AMELIORATING, OR TREATING SICKLE CELL DISEASE | The University of British Columbia (CA) | 2024-08-07 | — | — | EP | claimed |
| EP-4387657-A1 | LIPID NANOPARTICLE FORMULATIONS | Monash University (AU) | 2024-06-26 | — | — | EP | claimed |
| US-20240175024-A1 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | ALNYLAM PHARMACEUTICALS, INC. | 2024-05-30 | — | — | US | claimed |
| US-20240175012-A1 | GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO | UNIV BRITISH COLUMBIA (CA) | 2024-05-30 | — | — | US | claimed |
| WO-2024095213-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, AMELIORATING, OR TREATING SICKLE CELL DISEASE AND COMPOSITIONS AND METHODS FOR DISRUPTING GENES AND GENE SEGMENTS | INCISIVE GENETICS, INC. (CA) | 2024-05-10 | — | — | WO | claimed |
| US-11827883-B2 | Dosages and methods for delivering lipid formulated nucleic acid molecules | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-11-28 | — | — | US | claimed |
| WO-2023161873-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | INCISIVE GENETICS, INC. (CA) | 2023-08-31 | — | — | WO | claimed |
| WO-2023079465-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, AMELIORATING, OR TREATING SICKLE CELL DISEASE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-05-11 | — | — | WO | claimed |
| WO-2023019310-A1 | LIPID NANOPARTICLE FORMULATIONS | MONASH UNIVERSITY (AU) | 2023-02-23 | — | — | WO | claimed |
| WO-2022195553-A1 | GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-09-22 | — | — | WO | claimed |
| WO-2022115739-A1 | — | — | 2022-06-02 | — | — | WO | claimed |
| EP-3368089-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | TRANSLATE BIO MA, INC. (US) | 2018-09-05 | — | — | EP | claimed |
| WO-2017075038-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | RANA THERAPEUTICS, INC. (US) | 2017-05-04 | — | — | WO | claimed |
| CN-101205442-A | Ruthenium-barrier layer polishing slurry | ROHM & HAAS ELECT MAT (US) | 2008-06-25 | — | — | CN | claimed |
| US-6582687-B1 | Skin cleanser containing an alkali salt of N- acylamino acid and maltitolhydroxy aliphatic ether, or a hydroxy ether carboxylic acid-based anionic surfactant, or polyethylene powder, as well as water and an organic acid. Also, | SHISEIDO COMPANY, LTD. (JP) | 2003-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358652-A1 | LIPID NANOPARTICLE FORMULATIONS | LIPA, LIPC, PHOSPHO1 | DNM1 1107/4885CA12 1796/4885CA1 2870/4885 |
| US-20240293300-A1 | SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD | CUTA, SLC6A12, DSG1 | DNM1 3936/4885CA12 2028/4885CA1 4323/4885 |
| US-20240175024-A1 | DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES | POLM, POLRMT, ADAR | DNM1 1042/4885CA12 4439/4885CA1 4840/4885 |
| US-20250235559-A1 | GENE EDITING REPORTER SYSTEM AND GUIDE RNA AND COMPOSITION RELATED THERETO; COMPOSITION AND METHOD FOR KNOCKING OUT DNA WITH MORE THAN TWO GRNAS; GENE EDITING IN THE EYE; AND GENE EDITING USING BASE EDITORS | RBM26, RNASEL, MRTO4 | DNM1 2419/4885CA12 4771/4885CA1 4789/4885 |
| US-11827883-B2 | Dosages and methods for delivering lipid formulated nucleic acid molecules | POLM, POLRMT, ADAR | DNM1 1042/4885CA12 4439/4885CA1 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.